Education
About Us
Working with TipRanks
Follow Us
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.01M | $ -536.00K | $ 0.00 | $ 0.00 | $ -13.00K |
| Operating Income | $ -89.20M | $ -67.24M | $ -32.66M | $ -16.18M | $ -3.17M |
| EBITDA | $ -79.55M | $ -59.85M | $ -32.29M | $ -16.15M | $ -5.29M |
| Net Income | $ -80.56M | $ -60.39M | $ -31.17M | $ -16.24M | $ -5.31M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 179.48M | $ 127.46M | $ 127.75M | $ 99.60M | $ 1.58M |
| Total Assets | $ 196.59M | $ 138.26M | $ 181.23M | $ 106.59M | $ 2.19M |
| Total Debt | $ 3.65M | $ 4.64M | $ 4.96M | $ 5.63M | $ 58.00K |
| Net Debt | $ -36.17M | $ -31.37M | $ -24.56M | $ -93.97M | $ -1.52M |
| Total Liabilities | $ 19.80M | $ 17.07M | $ 10.75M | $ 130.40M | $ 10.60M |
| Stockholders' Equity | $ 176.79M | $ 121.19M | $ 170.47M | $ -23.81M | $ -8.41M |
| Cash Flow | |||||
| Free Cash Flow | $ -68.44M | $ -43.93M | $ -32.28M | $ -14.22M | $ -2.82M |
| Operating Cash Flow | $ -65.67M | $ -42.64M | $ -30.12M | $ -13.98M | $ -2.80M |
| Investing Cash Flow | $ -51.77M | $ 50.72M | $ -141.68M | $ -238.00K | $ -15.00K |
| Financing Cash Flow | $ 121.03M | $ -1.55M | $ 101.71M | $ 112.22M | $ 2.89M |